ArticleCancer medicine2021

Worse capecitabine treatment outcome in patients with a low skeletal muscle mass is not explained by altered pharmacokinetics.

Laura Molenaar-Kuijsten et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.